Integrated Vascular Systems Inc.

Atrial Fibrillation J&J Gets Long-Awaited Approval for AF Ablation Catheter; Medtronic Snaps up Ablation Frontiers The atrial fibrillation (AF) ablation market got a huge boost early this month when

The ophthalmic industry has traditionally stood alone, with its own device and pharmaceutical companies selling products marketed to specialists. So the announcement on January 12 that diversified gia

Venture capital firms, in pursuit of steady streams of early-stage opportunities, are establishing closer ties with the entrepreneurs and executives they feel can do it again. Tom Salemi Eager to secu

After an initial warm welcome for first-generation femoral artery closure devices—including a few high-profile exits—sales have stalled. Early devices are flawed, indicating the technical challenge is